The Department of Cardiothoracic Surgery is a recognized leader in heart, lung and esophagus surgery. Our experience with complex cardiothoracic issues and knowledge of the latest advances have helped to establish NewYork-Presbyterian|Weill Cornell Medicine as a major referral center for cardiovascular and thoracic patients from around the world.

Cardiac Surgery

The Division of Cardiac Surgery provides expert care to patients who need:

  • Coronary Artery Bypass Surgery
  • Valve repair/replacement
  • Aortic Aneurysm & Dissection Repair
  • Minimally Invasive & Robotic Heart Surgery
  • Ventricular Assist Device & Heart Transplant
Learn More
Cardiac Surgery team

Thoracic Surgery

The Division of Thoracic Surgery offers the most advanced surgical care for:

  • Lung & Esophageal cancers
  • Thymoma
  • Achalasia
  • Hyperhidrosis
  • Hiatal Hernia
  • Lung Volume Reduction for Emphysema
  • Tracheobronchomalacia (TBM)
Learn More
Thoracic Surgery team

Why Choose Weill Cornell?

NewYork-Presbyterian & Weill Cornell Medicine – Cardiothoracic Surgery

New Advances

The Why Behind the Lab Coat with Dr. Nasser K. Altorki

New Thoracic Clinical Trial

A Multicenter Phase II randomized trial of Neoadjvuant Radioimmunotherapy vs Chemotherapy in patients with Clinical Stages IB-III (N2) Non-Small Cell Lung Cancer (RICHIS)

RICHIS

Bypass Surgery May Offer Greater Long-Term Benefits Compared with Stents for Women

Dr. Mario Gaudino


Women with severe coronary heart disease causing narrowing or blockages in the arteries may derive greater long-term benefits from coronary artery bypass grafting compared with percutaneous coronary intervention, also known as stenting, according to a large study by Dr. Mario F.L. Gaudino and his team at Weill Cornell Medicine. Bypass surgery uses a blood vessel from another part of the body to reroute blood flow around a narrowed or blocked artery. Stenting is a minimally invasive procedure that uses a catheter to thread a tubelike stent through a blood vessel in the wrist or groin to the heart to open a fully or partially blocked artery.

Click Here to Learn More 

WCM's 2nd Annual Updates in International Interventional Pulmonology Symposium

Click Here to Learn More

Clinical Trials

The Cardiothoracic Surgery Department conducts a robust clinical trials program to evaluate the effectiveness of new treatments and medications that have the potential to improve the management of patients with heart, lung, and esophageal disease. The outcomes of heart, lung, and esophageal operations can be improved with technical innovations.

Current Clinical Trials

 

            US News Badge                    NY Best Regional Hospital Badge

Ranked #5 in Adult Cardiology & Heart Surgery Hospital in the nation and #1 in NYC by U.S. News and World Report

Ranked #1 in Best Regional Hospitals in U.S. News

     

  

America’s 50 Best Hospitals for Cardiac Surgery Award™ by Healthgrade

America’s 100 Best Hospitals for Cardiac Care Award™ by Healthgrade